Two-step ovarian cancer immunotherapy made from patients' own tumor benefits three quarters of trial patients
Sunday, April 7, 2013 - 10:00
in Health & Medicine
As many as three quarters of advanced ovarian cancer patients appeared to respond to a new two-step immunotherapy approach -- including one patient who achieved complete remission -- according to new research.